scispace - formally typeset
S

Suju Mathew

Researcher at Pfizer

Publications -  6
Citations -  77

Suju Mathew is an academic researcher from Pfizer. The author has contributed to research in topics: Green chemistry metrics & Alkylation. The author has an hindex of 4, co-authored 6 publications receiving 66 citations.

Papers
More filters
Journal ArticleDOI

Commercial Synthesis of (S,S)-Reboxetine Succinate: A Journey To Find the Cheapest Commercial Chemistry for Manufacture

TL;DR: In this paper, the development of a synthetic process for (S,S)-reboxetine succinate, a candidate for the treatment of fibromylagia, is disclosed from initial scale-up to deliver material for registrational stability testing through to commercial route evaluation and subsequent nomination.
Journal ArticleDOI

Application of a process friendly morpholine synthesis to (S,S)-Reboxetine

TL;DR: In this article, a morpholine ring system from epoxide and amino alcohol was constructed in a two-step process using a previous four-step synthesis, which was converted into a more efficient two-stage process.
Journal ArticleDOI

The use of environmental metrics to evaluate green chemistry improvements to the synthesis of ( S , S )-reboxetine succinate

TL;DR: The Pfizer Green Chemistry metrics program is described and exemplified with a case history involving the synthesis of (S,S)-reboxetine succinate as mentioned in this paper, which used a classical resolution approach and generated high levels of waste.
Journal ArticleDOI

The Lactol Route to Fesoterodine: An Amine-Promoted Friedel–Crafts Alkylation on Commercial Scale

TL;DR: In this paper, an amine-promoted Friedel-crafts alkylation of cinnamaldehyde with 4-hydroxymethyl phenol has been used successfully on commercial scale for the manufacture of fesoterodine, a muscarinic antagonist used for the treatment of overactive bladder.